Location History:
- Newburgh, NY (US) (1990 - 1995)
- Madison, CT (US) (1996 - 1997)
- Guilford, CT (US) (2001)
Company Filing History:
8 out of 3,580 
1 out of 1,567 
1 out of 832,761 Years Active: 1990-2001
Title: Richard H Kramss: A Pioneering Innovator in Cholinergic Compounds
Introduction
Richard H Kramss is a notable inventor based in Newburgh, NY, United States, recognized for his significant contributions to the field of medicinal chemistry. With a total of 10 patents to his name, he has made remarkable advancements in the development of compounds with potential therapeutic applications.
Latest Patents
Among his latest innovations are patents focused on substituted biphenyls and oxotremorine derivatives. One of his significant patents features substituted biphenyls that exhibit glucagon receptor antagonistic activity. These claimed compounds possess a formula that offers a new avenue for therapeutic exploration. Additionally, Kramss has disclosed novel substituted oxotremorine derivatives characterized by nitrogen, oxygen, or sulfur groups. This innovation encompasses prodrug forms of these derivatives and highlights their cholinergic activity. The patent also outlines methods for treating central nervous system diseases in mammals, detailing pharmaceutical preparations containing these compounds and the processes for their production.
Career Highlights
Throughout his career, Richard H Kramss has worked with esteemed organizations such as American Cyanamid Company, where he honed his skills in pharmaceutical research and development. His extensive experience in the industry has enabled him to break new grounds in medicinal chemistry.
Collaborations
Kramss has collaborated with remarkable colleagues, including Eugene J Trybulski and Herbert J Brabander. These partnerships reflect the collaborative spirit in the field of innovation, driving advancements in drug development and therapeutic solutions.
Conclusion
Richard H Kramss stands out as a significant figure in the realm of medicinal chemistry and patent creation. His contributions, particularly in the areas of substituted biphenyls and oxotremorine derivatives, exemplify the innovative spirit essential for addressing contemporary health challenges. As he continues to develop new compounds and methods, his work will undoubtedly impact the future of pharmacology.